Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Granger

Showing results (21-30 of 910) with videos related to

Pageof 91
Sort By:
Circulation|December 7, 2011
ST-segment-elevation myocardial infarction treatment and the seductive lure of observational analysesDaniel Muñoz, Christopher B Granger
Annals of Internal Medicine|October 21, 2014
Spironolactone did not reduce cardiac outcomes in symptomatic heart failure with preserved ejection fractionJacob Kelly, Christopher B Granger
American Heart Journal|November 10, 2012
Regionalization of ST-segment elevation myocardial infarction care: a task unfinishedAkshay Bagai, Christopher B Granger
JAMA|February 17, 2018
Improving Evidence for Implementation of Guideline-Based Care in Low- and Middle-Income CountriesChristopher B Granger, Denis Xavier
European Heart Journal|November 16, 2022
Bleeding and risk for future cardiovascular events in patients with atrial fibrillation on oral anticoagulation: major bleeding is a major problemJosephine Harrington, Christopher B Granger
Journal of the American College of Cardiology|July 30, 2016
Stroke Prediction in Atrial Fibrillation: Is it Black and White?Christopher B Granger, Kevin L Thomas
European Heart Journal|December 16, 2017
Traumatic injury: another unjustified reason to stop oral anticoagulation for atrial fibrillationSean D Pokorney, Christopher B Granger
Circulation|April 14, 2020
Preventing Atrial Fibrillation With Treatments for Diabetes MellitusChristopher B Granger, Kenneth W Mahaffey
Annals of Internal Medicine|September 16, 2015
Adding ezetimibe to simvastatin improved cardiovascular outcomes in stable acute coronary syndromeChristopher B Fordyce, Christopher B Granger
European Heart Journal|May 23, 2018
Uninterrupted apixaban for atrial fibrillation ablation is a reasonable alternative, but what is the significance of silent cerebral infarctions?Daniel J Friedman, Christopher B Granger
Pageof 91

Showing results (21-30 of 910) with videos related to

Sort By:
Pageof 91
Circulation|December 7, 2011
ST-segment-elevation myocardial infarction treatment and the seductive lure of observational analysesDaniel Muñoz, Christopher B Granger
Annals of Internal Medicine|October 21, 2014
Spironolactone did not reduce cardiac outcomes in symptomatic heart failure with preserved ejection fractionJacob Kelly, Christopher B Granger
American Heart Journal|November 10, 2012
Regionalization of ST-segment elevation myocardial infarction care: a task unfinishedAkshay Bagai, Christopher B Granger
JAMA|February 17, 2018
Improving Evidence for Implementation of Guideline-Based Care in Low- and Middle-Income CountriesChristopher B Granger, Denis Xavier
European Heart Journal|November 16, 2022
Bleeding and risk for future cardiovascular events in patients with atrial fibrillation on oral anticoagulation: major bleeding is a major problemJosephine Harrington, Christopher B Granger
Journal of the American College of Cardiology|July 30, 2016
Stroke Prediction in Atrial Fibrillation: Is it Black and White?Christopher B Granger, Kevin L Thomas
European Heart Journal|December 16, 2017
Traumatic injury: another unjustified reason to stop oral anticoagulation for atrial fibrillationSean D Pokorney, Christopher B Granger
Circulation|April 14, 2020
Preventing Atrial Fibrillation With Treatments for Diabetes MellitusChristopher B Granger, Kenneth W Mahaffey
Annals of Internal Medicine|September 16, 2015
Adding ezetimibe to simvastatin improved cardiovascular outcomes in stable acute coronary syndromeChristopher B Fordyce, Christopher B Granger
European Heart Journal|May 23, 2018
Uninterrupted apixaban for atrial fibrillation ablation is a reasonable alternative, but what is the significance of silent cerebral infarctions?Daniel J Friedman, Christopher B Granger
Pageof 91